NCT01304043已完成不适用
Observatoire Francophone Des Tumeurs Malignes Rares de l'Ovaire : Protocole de Prise en Charge Chez l'Adulte (Tumeurs Germinales et Des Cordons Sexuels)
ARCAGY/ GINECO GROUP1 个研究点 分布在 1 个国家目标入组 204 人开始时间: 2002年1月最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 204
- 试验地点
- 1
研究概览
简要总结
To take charge of the treatment in rare adult ovarian tumors with an homogenous manner (germinal and sexual cords tumors), at different stages of the disease.
详细描述
- to establish prognosis factors for the disease
- to proceed in a centralised examination of histologic laminas
- to reach in the long-term and homogenous follow-up of the patients
- to follow-up the long-term toxicities of the treatments given
- to analyse and follow-up the later fertility of the patients
- to evaluate the interest of setting a multi-disciplinary discussion forum on the Web
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •age > 18 years old
- •germinal or sexual cords ovary tumors histologically proven
- •first line or relapse treatment
- •written informed consent
排除标准
- •mental ineptitude to understand and follow the study
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
Unknown
Comparising result of histopathology examination to frozen section for diagnosing ovarian malignancyCTRI/2024/04/065770JAWAHAR LAL NEHRU MEDICAL COLLEGE
终止
2 期
Orteronel (TAK-700) in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors. The Greko II Study.Metastatic or Advanced Non-resectable Granulosa Cell Ovarian TumorsNCT02101684Grupo Español de Tumores Huérfanos e Infrecuentes10
已完成
不适用
Management of Ovarian Masses in Pediatric Patients: an Italian SurveyOvarian CystsPediatric ALLDiagnosisNCT05800613Fondazione Policlinico Universitario Agostino Gemelli IRCCS60
招募中
不适用
A Cohort Establishment Study of Total Management of Ovarian CancerTumor of Female Reproductive SystemOvarian CancerNCT06018935Sichuan Cancer Hospital and Research Institute500
已完成
不适用
Survival Data and Characteristics of Finisterian Patients Treated With PARP Inhibitors for Ovarian Cancer Between 2014 and 2019.Ovarian NeoplasmNCT04573933University Hospital, Brest54